BCL Enterprises (539621)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1.06 |
| Market Cap | ₹12.89 Cr |
| P/E Ratio | 123.6 |
| ROCE | 5.13% |
| ROE | 1.57% |
| Dividend Yield | 0% |
| Profit Growth | -55.56% |
| Debt/Equity | — |
| Sales Growth | -87.8% |
| 52-Week Range | ₹0.45 — ₹1.06 |
| Sector | Finance |
| Book Value | ₹0.58 |
Strengths
- Positive book value of ₹0.58 provides a tangible asset base, although the market price of ₹1.06 is above it.
- ROCE of 5.13% is positive, indicating some operating return before financing costs.
- Tiny ₹13 Cr market cap means a relatively small absolute improvement in earnings could affect per-share metrics significantly.
- The 52-week range shows the stock has held above its ₹0.45 low, suggesting some market participants see a stabilization.
Concerns
- Sales down 87.80% and latest quarterly revenue of ₹0 Cr indicate the business is effectively dormant.
- P/E of 123.60 and P/B of 1.83 on an ROE of 1.57% leave no margin of safety.
- Piotroski F-score of 3/9 points to weak financial health and operational distress.
- No dividend and undisclosed promoter holding reduce transparency and shareholder return.
AI Analysis
At first glance, BCL Enterprises reminds me that a stock chart and a business are two different things. This NBFC has a market cap of ₹13 Cr, yet its latest quarter shows sales of ₹0 Cr and net profit of ₹-0 Cr. Sales are down 87.80% and profits down 55.56%. That is not a temporary slowdown; that is a business that has nearly stopped. With a P/E of 123.60, the market is paying a rich multiple for earnings that are collapsing. Graham would ask: where is the margin of safety? I do not see it. The book value is ₹0.58, but I have to pay ₹1.06 for it, or 1.83 times book. A franchise earning a return of just 1.57% on equity and 5.13% on capital is not compounding wealth; it is consuming capital. The Piotroski score of 3 out of 9 tells me the financial health is weak. There is no dividend to compensate me while I wait, and promoter holding is not disclosed, leaving a question mark over alignment. In a microcap like this, any small news can move the price, but that is speculation, not investing. I cannot value a company that currently generates no meaningful revenue and gives me no evidence of a durable moat or pricing power. If there is a turnaround, it is not visible in these numbers. The price is at the top of its 52-week range of ₹0.45 to ₹1.06, but a rising share price is not a business. I would rather stay on the sidelines and wait for either a restored earnings stream or a price far below book value.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer